financetom
Business
financetom
/
Business
/
Scotiabank beats profit estimates on wealth management, capital market strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scotiabank beats profit estimates on wealth management, capital market strength
May 28, 2024 4:14 AM

May 28 (Reuters) - Bank of Nova Scotia ( BNS ) on

Tuesday reported better than expected quarterly earnings,

boosted by rises in brokerage revenue in Canada and mutual fund

fees overseas and by higher capital markets income.

The bank said net income at its global wealth management

unit rose 8% in February-April, its second quarter, driven by a

6% increase in Canada and a 19% rise in international markets,

which span across Latin America, the Caribbean and Central

America. Income from its capital markets segment rose 7%.

Scotiabank, Canada's third largest bank by assets, has

laid out a new plan under CEO Scott Thomson to focus on growth

in flourishing markets such as Mexico and the United States and

possibly exit underperforming markets such as Colombia.

However, higher loan loss provisions weighed on its Canadian

business, its biggest income generator, while loans in its home

market declined 1% and deposits grew 7%. In its international

business, net income fell 2%.

The lender has deliberately slowed its mortgage lending

amid elevated risks by being more selective while taking on new

clients and instead focused on growing deposits to reduce its

reliance on wholesale funding from larger investors.

"We are executing on our commitment to balanced growth

as our deposit momentum continues," CEO Thomson said in a

statement.

The top Canadian banks, which make up over 90% of the

overall banking market share, have been struggling amid high

interest rates that have weighed on consumers paying mortgages

and credit card bills. That in turn has forced the banks to set

aside more funds in case of loan defaults, weighing on profits.

Provisions for credit losses for Scotiabank increased to

C$1 billion ($733.94 million) in the quarter from C$709 million

in the year-ago period.

Rivals reporting results later in the week are also expected

to set aside bigger reserves, while investors are awaiting

commentary on how the lenders will navigate a prolonged high

interest-rate environment that has dented credit growth.

Scotiabank's net interest income - the difference between

what lenders earn on loans and pay out on deposits - rose to

C$4.69 billion in the quarter, compared with C$4.46 billion a

year earlier.

Its profit declined to C$2.11 billion, or C$1.58 per diluted

share, for the three months ended April 30, from C$2.16 billion,

or C$1.69 per diluted share, a year earlier.

Analysts were expecting C$1.56 per share, according to

LSEG data.

($1 = 1.3630 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Foran Up 8% After Announcing Strategic Investments By Fairfax, Agnico And Others; Makes Formal Construction Decision For Phase 1 At McIlvenna Bay And Advances Planning For Phase 2
Foran Up 8% After Announcing Strategic Investments By Fairfax, Agnico And Others; Makes Formal Construction Decision For Phase 1 At McIlvenna Bay And Advances Planning For Phase 2
Jul 15, 2024
03:31 PM EDT, 07/15/2024 (MT Newswires) -- Foran Mining Corporation ( FMCXF ) was at last look up near 9% after announcing earlier Monday a series of brokered and non-brokered strategic investments for up to $315 Million, consisting of a brokered equity private placement for which the company has received indications of interest from several of its existing shareholders, including...
Revolution Medicines Projects 2024 Net Loss of $560 Million to $600 Million; Provides Latest Cancer Drug Study Data
Revolution Medicines Projects 2024 Net Loss of $560 Million to $600 Million; Provides Latest Cancer Drug Study Data
Jul 15, 2024
03:36 PM EDT, 07/15/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) expects a net loss of $560 million to $600 million for full year 2024, according to a regulatory filing Monday. This includes estimated non-cash stock-based compensation expenses of $70 million to $80 million. The cash, cash equivalents and marketable securities are adequate to sustain operations until 2027. The...
US Silica Holdings Reports Preliminary Q2 Results
US Silica Holdings Reports Preliminary Q2 Results
Jul 15, 2024
03:34 PM EDT, 07/15/2024 (MT Newswires) -- US Silica Holdings ( SLCA ) reported Monday preliminary Q2 net income of $18.7 million to $19.7 million. Two analysts polled by Capital IQ expect $18.7 million. The company reported preliminary sales of $317 million to $318 million. Two analysts surveyed by Capital IQ expect $340.3 million. Financial closing procedures for the three...
Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Jul 15, 2024
03:39 PM EDT, 07/15/2024 (MT Newswires) -- Pulse Biosciences ( PLSE ) said Monday that it entered into an equity distribution agreement with sales agents Canaccord Genuity and Needham to sell up to $60 million in common stock from time to time. Pulse Biosciences ( PLSE ) will pay up to 3.0% of the gross sales price per share sold...
Copyright 2023-2025 - www.financetom.com All Rights Reserved